United Health Lawsuit Named Among FTC's Biggest Wins
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
How UnitedHealth and Rivals Made $7.3 Billion Marking Up Drugs: FTC
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
MedCity News16d
Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings
The Big Three PBMs have largely criticized the FTC report. A spokesperson for CVS Health argued that the FTC has drawn broad conclusions from “cherry-picked” specialty generic outliers in both ...
The FTC Finds United Health’s OptumRX Is Engaged In Widespread Price Gouging
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
CVS Health price target raised to $65 from $60 at Evercore ISI
Evercore ISI raised the firm’s price target on CVS Health (CVS) to $65 from $60 and keeps an Outperform rating on the shares. Given 2025 will ...
News Nation on MSN13d
UnitedHealth marked up lifesaving drugs as much as 1,000%: FTC
Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...
Rolling Out13d
Troubling FTC probe reveals PBMs’ price-gouging tactics
Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...
Evercore ISI Sticks to Its Buy Rating for CVS Health (CVS)
Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...